Clinical application of an enzyme-linked immunosorbent assay detecting hepatoma-specific γ-glutamyltransferase

Hepatology Research

Volumn 39, Issue 10, 2009, Pages 979-987

  Wang, Nian Yue ^a   Zhang, Dai ^b   Zhao, Wei ^a   Fang, Guo Xiang ^b   Shi, Yu Ling ^c   Duan, Mu Hao ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b JIANGSU UNIVERSITY   (China)

^c First People's Hospital of Xiangcheng   (China)

Author keywords

fetoprotein; glutamyltransferase; Enzyme linked immunosorbent assay; Hepatocellular carcinoma

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; DATURA STRAMONIUM EXTRACT; GAMMA GLUTAMYLTRANSFERASE; MONOCLONAL ANTIBODY;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER STAGING; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; ECHOGRAPHY; ENZYME ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

EID: 73849123976     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2009.00538.x     Document Type: Article

References (31)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-6.
2. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-17.
3. Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19: 329-38.
4. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003; 37: 429-42.
5. Gebo KA, Chander G, Jenckes MW et al. Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: a systematic review. Hepatology 2002; 36 (Suppl. 1): S84-92.
6. Imberti D, Fornari F, Sbolli G, Buscarini E, Squassante L, Buscarini L. Hepatocellular carcinoma in liver cirrhosis. A prospective study. Scand J Gastroenterol 1993; 28: 540-4.
7. Gupta S, Bent S, Kohlwes J. Test characteristics of alphafetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis. Ann Intern Med 2003; 139: 46-50.
8. Sherman M. Alphafetoprotein: an obituary. J Hepatol 2001; 34: 603-5.
9. Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology 1998; 27: 273-8.
10. Trevisani F, D'Intino PE, Morselli-Labate AM et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol 2001; 34: 570-5.
11. Nguyen MH, Garcia RT, Simpson PW, Wright TL, Keeffe EB. Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis. Hepatology 2002; 36: 410-17.
12. Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology 1998; 27: 273-8.
13. Sawabu N, Nakagen M, Ozaki K et al. Clinical evaluation of specific gamma-GTP isoenzyme in patients with hepatocellular carcinoma. Cancer 1983; 51: 327-31.
14. Kojima J, Kanatani M, Nakamura N et al. Electrophoretic fractionation of serum y-glutamyl transpeptidase in human hepatic cancer. Clin Chim Acta 1980; 106: 165-72.
15. Xu KC, Meng XY, Shi YC et al. The diagnostic value of a hepatoma-specific band of serum gamma-glutamyltransferase. Int J Cancer 1985; 36: 667-9.
16. Yao DF, Huang ZW, Chen SZ et al. Diagnosis of hepatocellular carcinoma by quantitative detection of hepatoma-specific bands of serum gamma-glutamyltransferase. Am J Clin Pathol 1998; 110: 743-9.
17. Xu K, Meng XY, Wu JW, Shen B, Shi YC, Wei Q. Diagnostic value of serum gamma-glutamyl transferase isoenzyme for hepatocellular carcinoma: a 10-year study. Am J Gastroenterol 1992; 87: 991-5.
18. Cui R, He J, Zhang F et al. Diagnostic value of protein induced by vitamin K absence (PIVKAII) and hepatoma-specific band of serum gamma-glutamyltransferase (GGTII) as hepatocellular carcinoma markers complementary to alpha-fetoprotein. Br J Cancer 2003; 88: 1878-82.
19. Jian W, Wang NY, Chen ZQ et al. A simple and specific method for detection of hepatoma specific GGT by affinity chromatography. Lab Med 2007; 38: 160-4.
20. Infection Branch and Hepatology Branch Chinese Medical Society. Infection disease, parasitosis and liver disease association of Chinese medical associate, program of prevention and cure of viral hepatitis (in Chinese). Zhonghua Ganzangbing Zazhi 2000; 8: 324-9.
21. Sobin LH, Wittekind C, eds. International Union Against Cancer (UICC). TNM Classification of Malignant Tumors, 5th edn. New York: John Wiley & Sons, Inc, 1997.
22. Schneider B. Combining laboratory tests for diagnostic decisions. Eur J Chil Biochem 1994; 32: 177-8.
23. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001; 38: 263-355.
24. Bellini M, Tumino E, Giordani R et al. Serum gamma-glutamyl-transpeptidase isoforms in alcoholic liver disease. Alcohol Alcohol 1997; 32: 259-66.
25. Kew MC, Wolf P, Whittaker D, Rowe P. Tumor-associated isoenzymes of gamma-glutamyl transferase in the serum of patients with hepatocellular carcinoma. Br J Cancer 1984; 50: 451-5.
26. Yao DF, Jiang D, Huang Z et al. Abnormal expression of hepatoma specific γ-glutamyl transferase and alteration of γ-glutamyl transferase gene methylation status in patients with hepatocellular carcinoma. Cancer 2000; 88: 761-9.
27. Brewer CF, Bhattacharyya L. Specificity of concanavalin A binding to asparagine-linked glycopeptides. A nuclear magnetic relaxation dispersion study. J Biol Chem 1986; 261: 7306-10.
28. Shaw LM, London JM, Petersen LE. Isolation of gamma-glutamyltransferase from human liver, and comparison with the enzyme from human kidney. Clin Chem 1978; 24: 905-15.
29. Arii S, Yamaoka Y, Futagawa S et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. Hepatology 2000; 32: 1224-9.
30. Takayama T, Makuuchi M, Hirohashi S et al. Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology 1998; 28: 1241-6.
31. Sakamoto M, Hirohashi S. Natural history and prognosis of adenomatous hyperplasia and early hepatocellular carcinoma: multi-institutional analysis of 53 nodules followed up for more than 6 months and 141 patients with single early hepatocellular carcinoma treated by surgical resection or percutaneous ethanol injection. Jpn J Clin Oncol 1998; 28: 604-8.